Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease

Exclusion criteria

• ✕. Total abstinence: When this is in line with the preferred and usual lifestyle of the patient. \[Periodic abstinence (e.g., calendar, ovulation, symptothermal, post-ovulation methods) and withdrawal are not acceptable methods of contraception\].
• ✕. Sterilization: have had surgical bilateral oophorectomy (with or without hysterectomy) or tubal ligation at least six weeks before taking study treatment. In case of oophorectomy alone, only when the reproductive status of the woman has been confirmed by follow up hormone level assessment.
• ✕. Male partner sterilization (with the appropriate post-vasectomy documentation of the absence of sperm in the ejaculate). \[For female study patients, the vasectomised male partner should be the sole partner for that patient\].
• ✕. Use of a combination of any two of the following (1+2 or 1+3 or 2+3):
• ✕. Use of oral, injected or implanted hormonal methods of contraception.
• ✕. Placement of an intrauterine device (IUD) or intrauterine system (IUS).
• ✕. Barrier methods of contraception: Condom or Occlusive cap (diaphragm or cervical/vault caps) with spermicidal foam/gel/film/cream/vaginal suppository.